Vienna Life Science Report 2018/19 Is Available Online At
Total Page:16
File Type:pdf, Size:1020Kb
*VUULJ[PUN3PML:JPLUJLZ*VUULJ[PUN3PML:JPLUJLZ 2018/19 2018/19 T R VIENNA LIFE SCIENCE REPO /,6$5HSRUW&RYHU'6LQGG/,6$5HSRUW&RYHU'6LQGG/,6$5HSRUW&RYHU'6LQGG Imprint This report is based on data obtained through the evaluation of a written survey among Austria's life science companies carried out by BIOCOM AG, Vienna in close cooperation with austria wirt- schaftsservice and LISAvienna in spring 2018. For more information please refer to page 44 ff. The editorial staff comprises Simone Ding, Sandra Wirsching, Uta Mommert (BIOCOM) and Brigitte Tem- pelmaier, Peter Halwachs and Johannes Sarx (LISAvienna). The layout was designed by Benjamin Röbig (BIOCOM). We thank all companies supporting this survey! The layout, graphics and other contents of this brochure of the Viennese life science cluster are protected by copyright law. Berlin, October, 2018 The Vienna Life Science Report 2018/19 is available online at www.LISAvienna.at. Order your free print copy via e-mail to [email protected]. Contact: LISAvienna, Walcherstr. 11A, A-1020 Vienna, www.LISAvienna.at BIOCOM AG, Lützowstr. 33-36, D-10785 Berlin, www.biocom.de Get connected and follow us at Xing LinkedIn Twitter ISSUU Flickr Vienna Life Science Report 2018/19 Preface The life science sector, including companies active in biotech- Life sciences, one of Vienna’s key business areas nology, pharma or the medical device business, is developing perfectly well both in Austria and Vienna. The Viennese life science sector has developed enormously in recent years. In all, some 37,600 people work at 554 compa- Vienna is playing a key role and accounts for a 50% share in nies, research institutions and other core organizations in the overall key figures characterizing the sector in Austria, such as field of life sciences in Vienna. In addition to providing attractive revenue, the number of companies and employees. The biotech jobs, the industry generates revenues of some €12.2 billion. business alone shows an even higher concentration in and Annual sales grew by 23% from 2014 to 2017 and employment around the city. Vienna is a knowledge and innovation hub where by 5%. academia is carrying out excellent research and provides indus- tries with graduates educated in a broad range of disciplines. The City of Vienna recognized future opportunities in the area of life sciences early on and continues to invest strategically to The figures discussed in this report have been derived from a complement governmental and international funding. In 2017, national survey, which was commissioned by the Austrian Fed- Vienna granted € 27.9 million to the life sciences, predominant- eral Ministry for Digital and Economic Affairs (BMDW) in order to ly through the Vienna Business Agency and the Vienna Science govern its activities for improving the framework in which the life and Technology Fund. Eighty-four ERC grants awarded to life science community acts and interacts. There is plenty of coop- science researchers in Vienna honor our outstanding academic eration between Vienna-based organizations and other national community. Vienna’s biotech and medical device start-ups, on life science nuclei such as Graz, Innsbruck and the additional the other hand, are hitting the headlines with multi-million-euro hot spots throughout the country. Indeed, mutually beneficial co- licensing deals, trade sales and Private Equity investments. operation among companies and between science and industry Biotech-based drug candidates, medical devices, laboratory is at the core of our concern. reagents and digital health solutions are center stage here. Innovative medicines and new digital medical devices save lives, Vienna offers ideal conditions for innovative companies from address demographic change, and benefit patients. Successful around the world and is a popular research and education companies have a huge socio-economic impact and guaran- center in Europe. The city also ranks among the top con- tee fiscal revenues. The report shows a positive development gress cities worldwide. Today, meetings on human medicine throughout, thus justifying our past expenditure on the life sci- dominate the entire conference sector in Vienna and enrich the ence sector, ranging from business plan competitions, men- regional scientific community. Our aim is to strengthen Vienna’s torship for young entrepreneurs, seed money, and funding of power further as a prime location for business. That way, we cooperative and translational research, to international marketing contribute to the future of revolutionary products and services, activities. The Ministry uses well-tried support instruments and ensure quality jobs and reinforce Vienna as a leading European we shall continue to invest in the Austrian life science sector. center for research and innovation. Each investment in the sector is an investment in life and in a brighter future. Peter Hanke Margarete Schramböck Executive City Councillor Christian Lendl / Austrian Federal Minister of Finance, Business, for Digital and Digital Innovation and © BMDW Economic Affairs © David Bohmann International Affairs 1 2 Vienna Life Science Report 2018/19 Preface Boosting innovation and growth! Vienna, the city for life and sciences It requires an innovative business plan, a strong patent, the best Vienna is safe, Vienna is stable – Vienna is the world’s most livable possible team and consistent support to become a life science city according to the rankings recently published by the Economist. success story. And this is an opinion held not only by Vienna’s citizens – more and more international companies are also setting up in the city. The city Austria’s federal promotional bank, the Austria Wirtschaftsservice is continuously finding ways to ensure that this remains the case (aws) was commissioned by the Austrian Ministry for Digital and and, to this end, the Vienna Business Agency provides a compre- Economic Affairs, to aid life science start-ups through customized hensive service for companies. programs. Through aws LISA (Life Science Austria) we offer a one- stop-shop support program to help innovative life science ideas to For a quarter of a century, projects in the life science sector have survive the journey from lab to market. You are invited to evalu- been implemented in close consultation and cooperation with ate and advance your business idea through our Best of Biotech universities and companies. As a local agency, we ensure that business plan competition. This is the first step to profit from our companies can find the right partners, grants and a fertile environ- in-house know-how, to receive financial support and to access the ment in Vienna. Personal contact is especially important to us in extensive aws network of life science managers, legal experts and this context. private equity investors. Strong infrastructure can make all the difference in life sciences in At aws, financial incentives are combined with advisory measures, particular, and it is for this reason that the Vienna Business Agency training and internationalization actions, in order to guide start-ups is offering low-cost laboratory and workspaces at the Vienna to economic independence as early as possible. aws PreSeed and BioCenter campus to research start-ups in the life science sector, aws Seedfinancing are among the most important founding grants as well as providing them with the opportunity to connect with the for the high tech industry in Austria. We enjoy assisting creative major players in the industry. founders through the challenging start-up phase and to making innovative ideas ready for the worldwide markets. By providing low- To help international life science expats find their feet in Vienna as interest loans, guarantees, subsidies and equity capital, we support quickly as possible, we provide an international point of contact – company growth and internationalization. our Expat Center located in the center of Vienna. The international team at the Vienna Business Agency has many years of experience The life sciences are booming, and LISAvienna as a successfully in the field of science and research and is familiar with the specific operating life science platform is supporting the enormous potential requirements based on many consultations. in this area. Marketable innovations not only support growth and employment, but also benefit the whole of society for example by We welcome everyone who wants to implement new ideas here in assisting potential medical advancements. As a promotional bank, Vienna, the city of life and sciences, and we are ready to support it is our goal to accompany start-ups on their path to success and you. thereby further strengthen the position of life sciences in Austria. © Vienna Business Agency / Peter Rigaud © aws / Katharina Gossow Edeltraud Stiftinger and Bernhard Sagmeister Gerhard Hirczi Managing Directors Managing Director Austria Wirtschaftsservice GmbH Vienna Business Agency 3 4 Vienna Life Science Report 2018/19 Preface Dear Readers! We are pleased to present the fourth Vienna Life Science Report. We have been summarizing key facts about Vienna’s thriving life sci- ence community and also providing a directory since 2010. This report will show you that not only is Vienna Austria’s most important life science hot spot, it is also highly rated by global players. The report includes a wealth of up-to-date facts, figures and interesting examples. The life science business in the heart of Europe is growing, as the following figures clearly show. In total, the report refers to 554 life science organizations in Vienna, employing 37,595 people in 2017. This represents significant growth by comparison with 35,730 em- ployees in 2014. The annual sales figures of Vienna’s life science companies have increased by 23 percent to € 12.2 billion. As you will learn in more detail from reading this publication, Vienna provides an excellent hub for start-ups. The report refers to 51 new companies founded in the city between 2015 and 2017. Sixty-three percent of them are active in the fields of research, development or manufacturing.